openPR Logo
Press release

Malaria Treatment Market Business Opportunities 2027 | Advanz, Mylan, Ipca Laboratories, Teva, Sun Pharmaceutical Industries

01-18-2021 10:07 AM CET | Health & Medicine

Press release from: The Insight Partners

Malaria Treatment Market Forecast to 2027

Malaria Treatment Market Forecast to 2027

Malaria remains a notable cause of death and illness among adults and children. Plasmodium parasites are the causative reason for malaria infection. Controlling malaria needs an organized approach, comprising immediate treatment and prevention with effective antimalarial agents. Malaria is typically prevalent in the hot climate. Anopheles mosquito is the causative agent of malaria, which transfers the parasite from one person to another. Malaria is highly prevailing in conditions where health care systems are inadequate and awareness is low. Malaria is a treatable disease if adequate treatment is received early. Delay in action may lead to critical implications, including death. Effective and prompt treatment is also necessary for controlling the spread of malaria. The cost of malaria is enormous for human and social beings as the disease typically attacks not once but repeatedly into affected victims. The World Bank and the World Health Organization (WHO) rank malaria as the single largest factor of disease in Africa, causing disability and premature mortality.

Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPRE00018229/?openpr-10144

In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

-Bayer AG
-Ipca Laboratories Ltd
-Olympus Corporation
-Abbott
-Sun Pharmaceutical Industries Ltd
-Sanofi
-Glaxosmithkline plc
-Novartis
-Mylan
-Teva
-Advanz

The global malaria treatment market is segmented on the treatment type, route of administration, and end-user. Based on treatment type, the global malaria treatment market is segmented into with vaccines, ani-malarial agents, diagnostics tests. Based on the route of administration the market is segmented into oral and parenteral. Based on the end-user, the malaria treatment market is segmented into hospitals, specialty clinics, and others.

The increasing prevalence of malaria in tropical and sub-tropical regions, and increased government funding to fight against malaria will spur the demand for malaria treatment market. Additionally, unmet market needs of managing malaria burden around the world, and rise in medical insurance in developing countries expected to boost the market growth to significant extent over the forecast period. However, lack or insufficient healthcare infrastructure in underdeveloped and developing regions and lack of awareness related to symptoms of malaria in developing countries are some the major factor which may restraint the growth of the market in the forecasted period.

To comprehend global Malaria Treatment market dynamics in the world mainly, the worldwide market is analyzed across major global regions: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

This research provides detailed information regarding the major factors influencing the growth of the Malaria Treatment Market in Global and Regional Level (drivers, restraints, opportunities, and challenges), forecast of the market size, in terms of value, market share by region and segment; regional market positions; segment and country opportunities for growth; New product developments, strengths and weaknesses, brand portfolio; Marketing and distribution strategies; challenges and threats from current competition and prospects; Key company profiles, SWOT, product portfolio and growth strategies.

Buy Complete Report at: https://www.theinsightpartners.com/buy/TIPRE00018229/?openpr-10144

The research provides answers to the following key questions:

1.What is the estimated growth rate of the market for the forecast period 2020–2027? What will be the market size during the estimated period?
2. What are the key driving forces responsible for shaping the fate of the Malaria Treatment market during the forecast period?
3. Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Malaria Treatment market?
4. What are the prominent market trends influencing the development of the Malaria Treatment market across different regions?
5. What are the major threats and challenges likely to act as a barrier in the growth of the Malaria Treatment market
6. What are the major opportunities the market leaders can rely on to gain success and profitability?

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaria Treatment Market Business Opportunities 2027 | Advanz, Mylan, Ipca Laboratories, Teva, Sun Pharmaceutical Industries here

News-ID: 2226309 • Views:

More Releases from The Insight Partners

Insect Pest Control - Obtain PDF Sample Copy
The Insect Pest Control Market size is projected to reach US$ 14.85 billion by 2031 from US$ 21.33 billion in 2024. The market is expected to register a CAGR of 5.4% during 2025-2031. The proactive health measures, combined with heightened consumer awareness about disease prevention, have boosted the demand for both professional pest control services and DIY products. The convergence of public health policies, regulatory vigilance, and increased risk perception
Denim Fabrics - Obtain PDF Sample Copy
The denim fabrics market size is projected to reach US$ 28.69 billion by 2031 from US$ 22.32 billion in 2024. The market is expected to register a CAGR of 3.8% during 2025-2031. The denim fabrics market is growing steadily owing to changing consumer preferences, fashion trends, and increasing accessibility. Denim has evolved from being a utilitarian fabric to a mainstream fashion item, appreciated for its flexibility, comfort, and ease. With
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope Till 2028
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope …
A new market study report by The Insight Partners on the Photomedicine Devices and Technologies Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. Get PDF Sample
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market

All 5 Releases


More Releases for Malaria

Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database. Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
03-08-2017 | Health & Medicine
TMR
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in